Laboratory of Intensive Care Medicine, Katholieke Universiteit Leuven, Herestraat 49, bus 503, B-3000 Leuven, Belgium.
Best Pract Res Clin Endocrinol Metab. 2011 Oct;25(5):745-57. doi: 10.1016/j.beem.2011.03.002.
Acutely ill patients typically present with low circulating T3 and increased reverse T3. When illness is severe and prolonged, also pulsatile TSH secretion and circulating T4 levels are low. This constellation of changes within the thyroid axis is referred to as the low T3 syndrome or non-thyroidal illness syndrome (NTI), and comprises both peripheral and central alterations in the thyroid axis. Acute alterations are dominated by changes in thyroid hormone binding, in thyroid hormone uptake by the cell and in the activity of the type-1 and type-3 deiodinase enzymes. Prolonged critical illness is associated with a neuroendocrine dysfunction characterized by suppressed hypothalamic thyrotropin-releasing hormone (TRH) expression, resulting in reduced stimulation of the thyrotropes whereby thyroidal hormone release is impaired. During prolonged critical illness, several tissue responses could be interpreted as compensatory to low thyroid hormone availability, such as increased expression of monocarboxylate transporters, upregulation of type 2 deiodinase activity and increased sensitivity at the receptor level. Whether the low T3 syndrome should be treated and which compound should be used remains to be further studied.
急性病患者通常表现为循环 T3 降低和反向 T3 增加。当疾病严重且持续时间较长时,促甲状腺激素分泌的脉冲和循环 T4 水平也会降低。这种甲状腺轴的一系列变化被称为低 T3 综合征或非甲状腺疾病综合征(NTI),包括甲状腺轴的外周和中枢改变。急性改变主要表现为甲状腺激素结合、细胞摄取甲状腺激素以及 1 型和 3 型脱碘酶活性的改变。长期严重疾病与神经内分泌功能障碍有关,其特征是下丘脑促甲状腺激素释放激素(TRH)表达受抑制,导致对促甲状腺细胞的刺激减少,从而甲状腺激素释放受损。在长期严重疾病期间,一些组织反应可能被解释为对低甲状腺激素可用性的代偿,例如单羧酸转运蛋白表达增加、2 型脱碘酶活性上调和受体水平的敏感性增加。低 T3 综合征是否应进行治疗以及应使用哪种化合物仍有待进一步研究。